If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Cyramza ® (ramucirumab) injection
10 mg/mL solutionThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Ramucirumab is supplied in single-dose vials as a sterile, preservative-free solution. Ramucirumab is supplied at a concentration of 10 mg/mL as 100 mg/10 mL (NDC 0002-7669-01) or 500 mg/50 mL (NDC 0002-7678-01) vials in individually packaged cartons.1
Recommended Storage
Keep the ramucirumab vial in the outer carton in order to protect from light.1
Do not freeze or shake the vial or the infusion solution.1
Store diluted infusion for no more than 24 hours at 2°C to 8°C (36°F-46°F) or 4 hours at room temperature (below 25°C [77°F]).1
Discard vial with any unused portion of ramucirumab.1
Enclosed Prescribing Information
CYRAMZA® (ramucirumab) injection, for intravenous use, Lilly
1. Cyramza [package insert]. Indianapolis, IN: Eli Lilly and Company; 2019.
Date of Last Review: March 22, 2019
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST